97 results
Page 3 of 5
8-K
288w5z 0jc
1 Oct 19
Adaptimmune Announces Appointment of Michael Garone as Interim Chief Financial Officer
8:14am
8-K
EX-99.1
qcfkx
1 Oct 19
Adaptimmune Announces Appointment of Michael Garone as Interim Chief Financial Officer
8:14am
8-K
EX-10.1
2m67esu g4o
27 Aug 19
Entry into a Material Definitive Agreement
8:39am
8-K/A
EX-99.1
asr f6ne3
27 Feb 19
CORRECTING and REPLACING — Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update
5:16pm
8-K
EX-99.1
d3g5z32tyd90t
27 Feb 19
Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update
7:43am
CORRESP
fdsun 334fe12cm
18 Oct 18
Correspondence with SEC
12:00am
8-K
gy3gliinl
24 Jul 18
GSK and Adaptimmune Complete Transition of NY-ESO SPEAR T-cell Therapy Program to GSK
7:36am
8-K
EX-99.1
eif6kiojpgy r95
24 Jul 18
GSK and Adaptimmune Complete Transition of NY-ESO SPEAR T-cell Therapy Program to GSK
7:36am